Elsevier

Chemical Engineering Journal

Volume 350, 15 October 2018, Pages 69-78
Chemical Engineering Journal

A polyethyleneimine-driven self-assembled nanoplatform for fluorescence and MR dual-mode imaging guided cancer chemotherapy

https://doi.org/10.1016/j.cej.2018.05.157Get rights and content

Highlights

  • A PEI-driven self-assembled lanthanide-doped nanocluster was synthesized.

  • The nanocluster has an ordered pore structure and good cisplatin loading capacity.

  • Release behavior of cisplatin from this nanoplatform was triggered by pH.

  • The nanoplatform showed good fluorescence/MR imaging and anticancer activity.

  • The side effects of cisplatin on vital organs were significantly mitigated.

Abstract

Multimode bioimaging probes with complementary advantages of imaging sensitivity and spatial resolution in a single drug delivery system have significant potential applications for clinical cancer diagnosis and chemotherapy. In this work, a polyethyleneimine-driven self-assembled lanthanide-doped CaF2 nanocluster was synthesized and used for fluorescence/MR imaging guided cancer chemotherapy. This nanocluster has an ordered pore structure and good cisplatin loading capacity. The release of cisplatin from this nanoplatform was triggered by acidic pH. In addition, this nanoplatform showed a high relaxation rate (4.91 mM−1 s−1) and fluorescence signal. The cell assay results indicated that the nanoplatform was effectively internalized by HeLa cells and showed a good fluorescence/MR imaging ability and cell inhibition effect. In vivo experiment, the nanoplatform displayed excellent fluorescence/MR imaging and anticancer activity. In addition, the side effects of cisplatin on vital organs were significantly mitigated. Thus, this multifunctional nanoplatform is an excellent candidate for fluorescence/MR imaging guided cancer chemotherapy.

Introduction

Cancer remains one of the leading causes of mortality worldwide and has attracted extensive concern [1], [2]. Multifunctional nanoplatforms with diagnostic and drug-delivery abilities are at the forefront of scientific research because of their potential applications in combating cancer [3], [4], [5], [6]. A nanoplatform with effective imaging ability can precisely locate tumors and monitor therapeutic effects during treatment [7], [8], [9]. Alternatively, a nanoplatform with a tumor-targeting drug-delivery role can enhance the specificity of anti-cancer drugs, and improve local concentrations at tumor site, while mitigating systemic toxicity [10], [11], [12]. To design an effective imaging nanoplatform, high spatial resolution and imaging sensitivity should be comprehensively considered to obtain a more precise tumor diagnosis [13], [14], [15], [16], [17], [18]. Magnetic resonance imaging (MRI) plays an important role in clinical diagnosis of cancer due to its penetration depth, noninvasiveness and high spatial resolution [19], [20]. However, MRI has poor sensitivity for detecting small tumor nodules [14], [21], [22]. Fluorescence imaging could be an effective tool for detecting small tumors because of its superior sensitivity but is limited by its unsatisfactory tissue penetration [23], [24], [25]. Therefore, the development of fluorescence/MR dual-mode imaging techniques is necessary to provide complementary information and enable the precise location of tumors.

As is known, lanthanides are also important elements to maintain the functionalities of proteins and enzymes in many physiological processes and can facilitate cellular uptake of certain drugs by increasing the cell permeability [26]. Besides, because of f-f intra orbital electronic transitions, lanthanide ions could lead to the photoluminescence of doped nanoparticles [27]. Lanthanides (e.g., Gd and Eu)-doped inorganic fluorides have been widely used for fluorescence/MR imaging because of their excellent fluorescence properties and paramagnetic properties [28], [29], [30], [31]. CaF2 crystals with good biocompatibility are an ideal host material because of their high lattice match with rare earth ions and high stability [29], [30], [31], [32]. Although many lanthanide-doped inorganic fluorides have been used for fluorescence and MR imaging, the use of polyethyleneimine (PEI) as a template to drive the self-assembly of CaF2 nanocrystals and prepare porous CaF2 nanoclusters has been not reported. As we know, PEI, a commonly used surfactant [33], can easily coordinate metal ions on the nanocrystal surface via its amino groups, thereby altering the crystal growth behavior for the synthesis of nanomaterials [34], [35], [36]. In addition, the amino groups of PEI on nanomaterials can coordinate with cisplatin (CDDP). This interaction can be easily destroyed under acidic conditions because the hydrogen proton can occupy the lone-pair electrons of the amino group, enabling pH-responsive drug-release behavior [6], [34], [37], [38].

Here, a PEI-driven self-assembled Gd-/Eu-doped CaF2 nanocluster (GECN) was successfully fabricated. The application of this nanoplatform for fluorescence/MR imaging and cancer chemotherapy was explored by loading CDDP, followed by coating with polyethylene glycol (PEG)-coupled folic acid (FA). The nanoplatform displayed good fluorescence/MR imaging effects in both in vitro and in vivo experiments. The systemic delivery of this nanoplatform in vivo could effectively suppress the tumor growth while mitigating the side effects of anticancer drugs on vital organs. Thus, this multifunctional nanoplatform is expected to be a promising candidate for simultaneous cancer diagnosis and chemotherapy.

Section snippets

Materials

Ethylene glycol, diethylene glycol, triethanolamine, FA, and dimethyl sulfoxide were provided by Sinopharm Co. (Shanghai, China). Gd(NO3)3·6H2O, Eu(NO3)3·6H2O, Ca(NO3)2·4H2O, NaBF4, PEI (MW: 10000), methoxypolyethylene glycol amine (PEG-NH2, MW: 10000), N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide (EDC), and N-hydroxysuccinimide (NHS) were provided by Aladdin Co. (Shanghai, China). CDDP was purchased from Sigma-Aldrich. Co. (USA). All of these chemicals were analytical grade and used without

Synthesis and characterization of GECN@CDDP@PEG-FA

The detailed synthesis of the prepared nanoplatform is summarized in Fig. 1a. First, the self-assembled GECN nanoparticles were prepared using a facile hydrothermal method. Subsequently, the nanoplatform was loaded with CDDP and further modified by PEG-FA to enhance its blood circulation time and tumor targeting. This nanoplatform, which combined excellent fluorescence/MR imaging and drug delivery role, could be a promising candidate for simultaneous cancer diagnosis and chemotherapy.

The TEM

Conclusions

In summary, we successfully synthesized a PEI-driven self-assembled Gd-/Eu-doped CaF2 nanocluster for use as a drug carrier and fluorescence/MR imaging agent. CDDP was chosen as the model drug and was effectively loaded into this nanoplatform. The release of CDDP was triggered by adjusting the pH. In addition, this nanoplatform showed a high r1 relaxation rate (4.91 mM−1 s−1) and fluorescence imaging ability. CLSM and TEM observation indicated that the nanoplatform was effectively internalized

Acknowledgments

The authors acknowledge financial support from the National Natural Science Foundation of China (Nos. 21407151, 31370983), the Science and Technology Major Project of Anhui Province (No. 17030701051), the Key Program of Chinese Academy of Sciences (No. KSZD-EW-Z-022-05), the Youth Innovation Promotion Association of Chinese Academy of Sciences (No. 2015385), and the Science and Technology Service Programs of Chinese Academy of Sciences (Nos. KFJ-STS-ZDTP-002 and KFJ-SW-STS-143), Anhui Science

References (45)

  • R.L. Siegel et al.

    Colorectal cancer statistics

    CA Cancer J. Clin.

    (2017)
  • A. Notaro et al.

    Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates

    Chem. Soc. Rev.

    (2017)
  • L. Lin et al.

    Yolk-shell nanostructures: design, synthesis, and biomedical applications

    Adv. Mater.

    (2018)
  • S. Wang et al.

    Core-satellite polydopamine-gadolinium-metallofullerene nanotheranostics for multimodal imaging guided combination cancer therapy

    Adv. Mater.

    (2017)
  • L. Yu et al.

    “Manganese extraction” strategy enables tumor-sensitive biodegradability and theranostics of nanoparticles

    J. Am. Chem. Soc.

    (2016)
  • X. Sun et al.

    A pH-responsive yolk-like nanoplatform for tumor targeted dual-mode magnetic resonance imaging and chemotherapy

    ACS Nano

    (2017)
  • D. Ni et al.

    Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents

    Chem. Soc. Rev.

    (2017)
  • H.B. Na et al.

    Inorganic nanoparticles for MRI contrast agents

    Adv. Mater.

    (2009)
  • Z. Cheng et al.

    Porous polymersomes with encapsulated Gd-labeled dendrimers as highly efficient MRI contrast agents

    Adv. Funct. Mater.

    (2009)
  • G. Yang et al.

    Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses

    Nat. Commun.

    (2017)
  • D. Peer et al.

    Nanocarriers as an emerging platform for cancer therapy

    Nat. Nanotechnol.

    (2007)
  • C. Wang et al.

    Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy

    Biomaterials

    (2010)
  • Cited by (25)

    • Biodegradable two-dimensional nanomaterials for cancer theranostics

      2022, Coordination Chemistry Reviews
      Citation Excerpt :

      In recent years, due to the great potential of 2D nanomaterials, new candidates for cancer diagnosis and treatment are developing rapidly. Besides enhancing drug targeting delivery, new nanomedicines have also combined other advanced treatment strategies (such as photothermal/photodynamic therapy (PTT/PDT), radiotherapy, catalytic therapy, etc.) and imaging features [37–40]. However, it is disappointing that many nanosystems have been found to be unable to meet in vivo biosafety requirements, so there is growing scientific and clinical interest in designing and developing novel therapies that are both highly biocompatible and highly therapeutic.

    • Galvanic exchange-induced growth of Au nanocrystals on CuS nanoplates for imaging guided photothermal ablation of tumors

      2020, Chemical Engineering Journal
      Citation Excerpt :

      Therefore, Cu2-xE nanomaterials can be used as efficient nanoagents for the PTT of tumors. To improve the photothermal therapeutic efficiency as well as reduce side-effects, simultaneous imaging of tumors can be adopted to evaluate the most favorable doses, irradiation region, and irradiation time [15–20]. For obtaining the simultaneous imaging and PTT abilities, one of the efficient strategies is to construct nanocomposites with imaging and photothermal compositions.

    • A biomimetic one-pot synthesis of versatile Bi<inf>2</inf>S<inf>3</inf>/FeS<inf>2</inf> theranostic nanohybrids for tumor-targeted photothermal therapy guided by CT/MR dual-modal imaging

      2019, Chemical Engineering Journal
      Citation Excerpt :

      Nevertheless, CT is confined significantly in distinguishing different soft tissues with similar densities [5,6]. Encouragingly, MRI, which is widely used in clinical medicine but has lower relatively temporal resolution, can give elaborate soft tissue details and structural information on lesions [7]. Moreover, CT and MRI have significant clinical complementation [8].

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text